BFC Planning’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
KCM
SL
BFC Planning's GOSS Position: Q3 2026 in Review
BFC Planning held its Gossamer Bio (GOSS) position steady in Q3 2026 at 78 shares worth $924. The position accounts for ﹤0.01% of the portfolio, ranked #3177.
BFC Planning first reported a position in GOSS in Q3 2024 and has held it in 8 quarters since. The position peaked at $19.4K in Q4 2025. 50 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.
- BFC Planning held 78 shares of Gossamer Bio worth $924 as of Q3 2026.
- BFC Planning left its Gossamer Bio share count unchanged in Q3 2026.
- Gossamer Bio made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3177 holding.
- BFC Planning first reported a position in Gossamer Bio in Q3 2024 and has held it in 8 quarters since.
- BFC Planning's Gossamer Bio position peaked at $19.4K in Q4 2025.
- 50 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.